Krystal Biotech Inc (KRYS)
164.75
+3.92
(+2.44%)
USD |
NASDAQ |
Dec 20, 16:00
165.06
+0.31
(+0.19%)
After-Hours: 20:00
Krystal Biotech Market Cap: 4.738B for Dec. 20, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bioventus Inc | 697.47M |
| ADMA Biologics Inc | 4.113B |
| Alnylam Pharmaceuticals Inc | 31.66B |
| Amicus Therapeutics Inc | 2.928B |
| Insmed Inc | 12.60B |
Market Cap Related Metrics
| PE Ratio | 92.56 |
| PS Ratio | 20.07 |
| Price to Book Value | 5.349 |
| Price to Free Cash Flow | 83.48 |
| Price | 164.75 |
| Earnings Yield | 1.08% |
| Operating PE Ratio | 74.62 |
| Normalized PE Ratio | 56.65 |